Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression

被引:0
|
作者
Qingqing Wei [1 ,2 ,3 ]
Changning Xue [1 ,2 ,3 ]
Mengna Li [1 ,2 ,3 ]
Jianxia Wei [1 ,2 ,3 ]
Lemei Zheng [1 ,2 ,3 ,4 ]
Shipeng Chen [1 ,2 ,3 ]
Yumei Duan [1 ,2 ,3 ]
Hongyu Deng [1 ,2 ,4 ]
Faqing Tang [1 ,2 ,4 ]
Wei Xiong [1 ,2 ,3 ]
Ming Zhou [1 ,2 ,3 ,4 ]
机构
[1] NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
[2] Cancer Research Institute and School of Basic Medical Sciences, Central South University
[3] The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University
[4] Hunan Key Laboratory of Oncotarget Gene, Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R730 [一般性问题];
学科分类号
100214 ;
摘要
Ferroptosis is an iron-dependent regulatory cell necrosis induced by iron overload and lipid peroxidation. It occurs when multiple redoxactive enzymes are ectopically expressed or show abnormal function. Hence, the precise regulation of ferroptosis-related molecules is mediated across multiple levels, including transcriptional, posttranscriptional, translational, and epigenetic levels. N6-methyladenosine(m6A) is a highly evolutionarily conserved epigenetic modification in mammals. The m6A modification is commonly linked to tumor proliferation, progression, and therapy resistance because it is involved in RNA metabolic processes. Intriguingly, accumulating evidence suggests that dysregulated ferroptosis caused by the m6A modification drives tumor development. In this review, we summarized the roles of m6A regulators in ferroptosis-mediated malignant tumor progression and outlined the m6A regulatory mechanism involved in ferroptosis pathways. We also analyzed the potential value and application strategies of targeting m6A/ferroptosis pathway in the clinical diagnosis and therapy of tumors.
引用
收藏
页码:1119 / 1132
页数:14
相关论文
共 50 条
  • [31] Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
    Yao, Jiali
    Song, Yeke
    Yu, Xiaoping
    Lin, Zhijie
    MOLECULAR MEDICINE, 2023, 29 (01)
  • [32] Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer
    Jiali Yao
    Yeke Song
    Xiaoping Yu
    Zhijie Lin
    Molecular Medicine, 29
  • [33] N6-methyladenosine modification: A potential regulatory mechanism in spinal cord injury
    Liu, Derong
    Fan, Baoyou
    Li, Jinze
    Sun, Tao
    Ma, Jun
    Zhou, Xianhu
    Feng, Shiqing
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [34] Role of N6-methyladenosine in tumor neovascularization
    Zhao, Lu
    Li, Qinshan
    Zhou, Tongliang
    Liu, Xuan
    Guo, Jing
    Fang, Qing
    Cao, Xiaoxue
    Geng, Qishun
    Yu, Yang
    Zhang, Songjie
    Deng, Tingting
    Wang, Xing
    Jiao, Yi
    Zhang, Mengxiao
    Liu, Honglin
    Tan, Haidong
    Xiao, Cheng
    CELL DEATH & DISEASE, 2024, 15 (08):
  • [35] N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer
    Song, Yanni
    Zheng, Chaojing
    Tao, Yangbao
    Huang, Rui
    Zhang, Qian
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [36] Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
    Zhu, Yong-fu
    Wang, Shu-Jie
    Zhou, Jie
    Sun, Ye-han
    Chen, You-mou
    Ma, Jia
    Huo, Xing-xing
    Song, Hang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] N6-Methyladenosine modification of LINC00901 promotes pancreatic cancer progression
    Peng, Wan-Xin
    Yang, Liu
    Mo, Yin-Yuan
    CANCER RESEARCH, 2020, 80 (16)
  • [38] The link between N6-methyladenosine modification and psoriasis
    Cui, L.
    Cai, J.
    Hu, C.
    Yu, Y.
    Shi, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S6 - S6
  • [39] Role of N6-methyladenosine Modification in Cardiac Remodeling
    Choy, ManTing
    Xue, Ruicong
    Wu, Yuzhong
    Fan, Wendong
    Dong, Yugang
    Liu, Chen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [40] Advances in detecting N6-methyladenosine modification in circRNAs
    Ma, Lixia
    He, Li-na
    Kang, Shiyang
    Gu, Bianli
    Gao, Shegan
    Zuo, Zhixiang
    METHODS, 2022, 205 : 234 - 246